The Effects of Hyaluronic Acid on Skin Health

Inclusion criteria

• Informed Consent signed by the subject
• Healthy adult volunteers aged 18 to 50 years at the time of inclusion
• Ability and willingness to comply with all study procedures and visits as required by the protocol.

Exclusion criteria

• Pregnant or breastfeeding women, or women unwilling to use an effective method of contraception, as the use of the investigational medical device is contraindicated according to the Instructions for Use (IFU)
• Known hypersensitivity to any of the product ingredients, as well as fructose intolerance.
• Any skin disease or systemic disease that, in the opinion of the investigator, may affect the treatment area or interfere with study assessments.
• Presence of any skin alteration at the test sites, including but not limited to scars, tattoos, or other visible skin lesions.
• History of hypertrophic scars or keloid formation or a similar abnormal wound healing.
• Presence of terminal hairs at the designated test sites.
• Current use of any medication or treatment that, in the judgment of the investigator, may interfere with the interpretation of study results or pose a safety concern.
• Body Mass Index (BMI) > 36 kg/m².
• Any medical, psychological, psychiatric, or cognitive condition, including drug or alcohol abuse, language barriers, or other circumstances that, in the opinion of the investigator, may impair the subject's ability to understand the study information, comply with the investigation procedures, or complete the investigation.
• Participation in another clinical investigation involving an investigational medicinal product or medical device within the 30 days prior to enrolment.
• Previous enrolment in the current investigation.
• Enrolment of the principal investigator, sub-investigators, their family members, employees, or other dependent persons.